Insight on Pharmaceuticals and Healthcare in North America

The following industries match your search criteria:

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | » »|

Results are sorted by relevance. Click on heading titles to sort results by different field.

Type Product title / description Pub Price
Report
Report

Market and Product Forecasts: Depression – Further clinical failures dampen growth prospects

Assessment of the current and future depression market using patient-based forecasting methodology. The analysis is designed to understand the future dynamics of the depression drug market, with a particular focus on pipeline therapies.

Published By Datamonitor
19 Jan 2012 $6400
Buy
Report
Report

Product Profiles: Depression – Next generation vies for second-line patients

In-depth analysis of key brands and pipeline agents indicated for the treatment of depression. Provides a comparative evaluation of clinical and commercial drug attributes to determine competitiveness in the marketplace.

Published By Datamonitor
17 Jan 2012 $6400
Buy
Report
Report

Market and Product Forecasts: Insulin Antidiabetics – Biosimilar entry not enough to stem growth of insulin analogs

Datamonitor patient-based forecast of leading insulin brands and pipeline products for 2011 to 2020. Coverage: US, Japan, France, Germany, Italy, Spain, and the UK

Published By Datamonitor
28 Dec 2011 $6400
Buy
Report
Report

Market and Product Forecasts: Colon Cancer - Older drugs remain dominant as new approvals struggle in saturated market

This report and accompanying deliverable provides forecasts for colon cancer drugs in the seven major markets from 2011-20. Including in-depth analysis of the colon cancer market in individual countries and molecule dynamics of the key therapies.

Published By Datamonitor
22 Dec 2011 $6400
Buy
Report
Report

Market and Product Forecasts: Antihypertensives – ARB generics drive market decline

Datamonitor patient-based forecast of leading antihypertensive brands and pipeline products. Coverage: US, Japan, France, Germany, Italy, Spain, and the UK

Published By Datamonitor
22 Dec 2011 $6400
Buy
Report
Report

Market and Product Forecasts: Prostate Cancer

Prostate cancer market growth is driven by uptake of recent approved therapies and launch of key pipeline candidates. Datamonitor forecasts continued expansion over the forecast period across the seven major markets at a CAGR of 8%.

Published By Datamonitor
21 Dec 2011 $6400
Buy

Exclusive online offer: order this report by November 9th and save 20%

To take advantage of this offer enter Promo Code BIO2012 when prompted in the checkout

More information

Report
Report

Biosimilars: Market Entry Strategies

This report provides an analysis of strategies employed by the top 50 pharma companies that are active or plan to enter the biosimilars sector in the future, together with an analysis of biosimilar deal trends among the top 50 pharma companies.

Published By Datamonitor
20 Dec 2011 $2800
Buy
Case Studies
Case Studies

GlaxoSmithKline: Through Mergers and Acquisitions to Success

GlaxoSmithKline is the world's second largest pharmaceutical company with annual turnover exceeding $30 billion. This case study offers insight into the company’s strategy, its assets and strengths, while at the same time highlighting its weaknesses.

Published By MarketLine
19 Dec 2011 $495
Buy
Report
Report

Product Profiles: Insomnia - Orexin receptor antagonists may yet refresh the insomnia market

In-depth analysis of key prescription brands and pipeline agents for the treatment of insomnia. Provides a comparative evaluation of clinical and commercial drug attributes to determine competitiveness in the marketplace.

Published By Datamonitor
19 Dec 2011 $6400
Buy
Report
Report

Canada: Pharmaceutical Industry Infrastructure Overview

This report provides an overview of research and development, manufacturing, outsourcing, and distribution trends, as well as infrastructure profiles for the leading pharmaceutical companies in Canada.

Published By Datamonitor
16 Dec 2011 $1520
Buy

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | » »|

No help is available.